Medicap Healthcare Limited IPO Details

MAINBOARD

Medicap Healthcare IPO DRHP (Draft Red Herring Prospectus) has been Filed With SEBI.

The Lead Managers for Medicap Healthcare IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is Aryaman Financial Services Limited. To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.

For detailed information, Refer to the Medicap Healthcare Limited DRHP.

Medicap Healthcare IPO Details

Open Date
-
Close Date
-
Listing Date
-
Issue Price
₹0 - ₹0
Face Value
₹10 per share
Lot Size
0
GMP
₹0
Issue Type
IPO
Listing On
NSE, BSE
Type
Book Built Issue
Share holding pre issue
24500000
Share holding post issue
-
Total Issue Size
-
Fresh Issue
-
Offer for Sale
-
DRHP Status
Filed With SEBI

Medicap Healthcare IPO Lot Size

ApplicationLotsSharesAmount
To be announced

Medicap Healthcare IPO Reservation

Promoter Holding

Pre Issue:98%
Post Issue:-
Promoter Names:
Kamalkumar Aggarwal, Rajveer Kamal Aggarwal, Minal Aggarwal

Documents

Medicap Healthcare IPO Valuations

ROE:27.30%
ROCE:17.67%
DEBT/EQUITY:0.67
RONW:24.02%
PAT MARGIN:24.58%

Medicap Healthcare Financial Information

Period Ended31 Mar 202531 Mar 202431 Mar 2023
Assets216.29105.8998.35
Total Income109.91103.0572.60
Profit After Tax26.6223.9014.79
EBITDA37.1635.6822.67
NET Worth110.8484.2160.32
Total Borrowing88.096.9826.77
Amount in ₹ Crore

About Medicap Healthcare IPO

Incorporated on 2 June 2017, Medicap Healthcare Limited is in pharmaceutical packaging sector specializes in the production of pharmaceutical closures, including Euro Head caps and bottle preforms.

The company manufactures pharmaceutical packaging solutions, especially closures (e.g. Euro Head caps), Blood Collection Tubes (BCT), and components for Water for Injection (WFI) supply. It supplies pharma and healthcare industries.

The company operates from a 6,732 sq ft ultra-modern, state-of-the-art manufacturing facility with the latest technology.

Product Offerings:

  • Euro Head Caps
  • Bottle Preforms
  • Miscellaneous (includes plastic and protector cap)

As on August 31, 2025, the company had 66 permanent employees.

Competitive Strengths:

  • Well-positioned to capture favorable industry tailwinds in the growing pharma packaging caps and closure and bottle preforms market.
  • Strategically located manufacturing facility coupled with quality-centric and precision-driven manufacturing infrastructure driving production efficiency.
  • Robust domestic and global market presence driving sustainable growth.
  • Long standing relationships with customers and suppliers with track record of repeat orders.
  • Financial performance and growth due to specialized products.

 

 

Strength Of Medicap Healthcare IPO

To be announced

Risk Of Medicap Healthcare IPO

To be announced

Objectives Medicap Healthcare IPO

1. Purchase of plant and machinery for the existing Manufacturing Unit

2. Repayment or pre-payment, in full or part, of certain borrowings availed by the Company

3. Further Investment in the Subsidiary KASR Healthcare Private Limited for Repayment or pre-payment, in full or part, of certain borrowings availed by the Subsidiary Company

4. General Corporate Purposes

Company Contact Details

Medicap Healthcare Ltd
E-73,
GIDC Manjusar,
Vadodara, Gujarat, 391775
Phone: +91 97734 72846
Email: Investor.relations@medicapinc.com
Website: https://medicaphealthcare.in/

Registrar Contact Details

Name: Kfin Technologies Limited
Phone: +91-40-67162222

Comments